Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Obsessive-Compulsive Disorder Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising number of obsessive-compulsive disorder cases
5.1.1.2. Increasing awareness about OCD and its treatment
5.1.1.3. Favorable insurance for OCD drugs
5.1.2. Restraints
5.1.2.1. Patent expiry of the patented drugs
5.1.3. Opportunities
5.1.3.1. Favorable government initiatives and increasing investment in R&D for novel drug product
5.1.3.2. Increasing product approvals for new OCD drugs
5.1.4. Challenges
5.1.4.1. Strict government regulations for drug authorization
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Obsessive-Compulsive Disorder Drugs Market, by Type
6.1. Introduction
6.2. SSRI
6.3. TCA

7. Obsessive-Compulsive Disorder Drugs Market, by Application
7.1. Introduction
7.2. Clinic
7.3. Hospital
7.4. Research Institute

8. Americas Obsessive-Compulsive Disorder Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Obsessive-Compulsive Disorder Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Obsessive-Compulsive Disorder Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Amneal Pharmaceuticals LLC
12.1.3. Apotex Inc.
12.1.4. Aurobindo Pharma USA
12.1.5. Biohaven Pharmaceutical Holding Co. Ltd.
12.1.6. Dr. Reddy’s Laboratories Ltd.
12.1.7. Eli Lilly, and Company
12.1.8. GlaxoSmithKline PLC
12.1.9. H. LUNDBECK A/S
12.1.10. Lannett Co Inc.
12.1.11. Lupin Pharmaceuticals, Inc.
12.1.12. Mallinckrodt Pharmaceuticals
12.1.13. Par Pharmaceutical, Apotex Inc.
12.1.14. Pfizer Inc.
12.1.15. Sebela Pharmaceuticals, Inc.
12.1.16. Sun Pharmaceutical Industries Ltd.
12.1.17. Teva Pharmaceutical Industries Ltd.
12.1.18. Viatria Inc.
12.1.19. Zydus Pharmaceuticals, Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET RESEARCH PROCESS
FIGURE 2. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET DYNAMICS
FIGURE 7. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY SSRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TCA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. CANADA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. CANADA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. MEXICO OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. MEXICO OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CHINA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. CHINA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. INDIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. INDIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. JAPAN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. JAPAN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. THAILAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. THAILAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. DENMARK OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EGYPT OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. EGYPT OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FINLAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. FINLAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. FRANCE OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. ITALY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NORWAY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. NORWAY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. POLAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. POLAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. QATAR OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SPAIN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TURKEY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. TURKEY OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 99. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 100. OBSESSIVE-COMPULSIVE DISORDER DRUGS MARKET LICENSE & PRICING